Frontrunners emerge in race for Covid-19 vaccine
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
January 27, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, JANUARY 27, 2023
Frontrunners emerge in race for Covid-19 vaccine

Coronavirus chronicle

BSS/AFP
19 November, 2020, 01:55 pm
Last modified: 19 November, 2020, 04:19 pm

Related News

  • India launches world’s 1st intranasal Covid vaccine
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • China says Covid deaths down by nearly 80 percent
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • US proposes once-a-year Covid shots for most Americans

Frontrunners emerge in race for Covid-19 vaccine

Here’s an update on the quest for a magic bullet against the coronavirus that has already killed more than a million people worldwide

BSS/AFP
19 November, 2020, 01:55 pm
Last modified: 19 November, 2020, 04:19 pm
File Photo: A woman holds a small bottle labbeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration
File Photo: A woman holds a small bottle labbeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration

Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective Covid-19 vaccine, both to meet urgent medical need and for the potential payday.

Here's an update on the quest for a magic bullet against the coronavirus that has already killed more than a million people worldwide:

How Many In The Pipeline? 

The World Health Organization (WHO) has identified 48 "candidate vaccines" at the stage of clinical trials in humans, up from 11 in mid-June.

Twelve of them are at the most advanced "phase 3" stage, in which a vaccine's effectiveness is tested on a large scale, generally tens of thousands of people across several continents.

Earlier this month, a US-German collaboration between Pfizer and BioNTech scored a major breakthrough by announcing the results of its phase 3 trial for its mRNA vaccine.

It said the vaccine had proven 90 percent effective in preventing Covid-19 symptoms and did not produce adverse side effects among thousands of volunteers.

On Wednesday it announced further trial results, showing the vaccine to be 95 percent effective.

"Efficacy was consistent across age, gender, race and ethnicity demographics," the company said.

Pfizer is currently seeking Emergency Use Authorization from the US Food and Drug Administration (FDA) and expects to roll out 1.3 billion doses by the end of next year.

On Monday, US biotech firm Moderna said its vaccine was almost 95 percent effective.

Moderna plans to submit applications for emergency approval in the US and around the world within weeks, and says it expects to have approximately 20 million doses ready to ship in the US by the end of the year.

It says it's on track to manufacture between 500 million to a billion doses globally in 2021.

In addition, several state-run Chinese labs and a European project led by the University of Oxford and AstraZeneca are thought to be among the more promising candidate vaccines.

Russia has already registered two Covid-19 vaccines, even before clinical trials were completed.

What Kind Of Vaccines?

Some methods for making a vaccine are tried-and-tested, while others remain experimental.

Inactivated "classic" vaccines use a virus germ that has been killed, while others use a weakened or "attenuated" strain.

These vaccines work when the body treats the deactivated pathogen as if it were active, producing antibodies to kill it without endangering the patient with full infection.

So-called "sub-unit" vaccines contain a fragment of the virus or bacteria they are derived from to produce a similar immune response.

"Viral vector" varieties deliver fragments of viral DNA into cells, often hitching a lift off of other virus molecules.

For example, a measles virus modified with a coronavirus protein — the apparatus SARS-CoV-2 uses to latch on to human cells — can by deployed to provide immunity to Covid-19.

Both Pfizer's and Moderna's vaccines are based on cutting-edge technology that uses synthetic versions of molecules called messenger RNA to hack into human cells, and effectively turn them into vaccine-making factories.

Safety First

Trials of two candidate vaccines — made by Johnson & Johnson and Eli Lilly — were "paused" recently over safety concerns.

But that is not necessarily bad news, said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.

"The fact that trials are paused should indicate that there should be confidence that the whole process of monitoring the safety of trial participants is working well," he said.

Recent cases in which recovered Covid patients were infected a second time with a new strain also raise the question of how long vaccines might last.

In October, the US FDA said it would need to see two months of follow up data after vaccination before giving emergency authorisation for any vaccine use.

"What is different for Covid-19 vaccines is that speed of development and potential approval is much faster due to the public health emergency," noted the European Medicines Agency (EMA). But even that pressing need cannot overcome the rules.

"Before approval, all vaccines in the European Union are evaluated against the same high standards as any other medicine," the EMA said in a statement.

Top News

Coronavirus Vaccine / covid-19 vaccine / Vaccine progress / Coronavirus Pandemic / Coronavirus / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infograph: TBS
    State banks spend 80% of their forex for govt imports in H1
  • Manufacturers feel the pinch as consumers tighten belt
    Manufacturers feel the pinch as consumers tighten belt
  • Production halted in 8 power plants of Chattogram
    Production halted in 8 power plants of Chattogram

MOST VIEWED

  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC
  • People embrace at the international arrivals gate at Beijing Capital International Airport after China lifted the coronavirus disease (COVID-19) quarantine requirement for inbound travellers in Beijing, China January 8, 2023. REUTERS/Thomas Peter
    China says peak Covid infections exceeded 7 million daily, deaths more than 4,000 daily
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    US proposes once-a-year Covid shots for most Americans

Related News

  • India launches world’s 1st intranasal Covid vaccine
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • China says Covid deaths down by nearly 80 percent
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • US proposes once-a-year Covid shots for most Americans

Features

Sketch:TBS

Why we need consumer education for consumer wellbeing

1h | Thoughts
Dr Ahsan H Mansur, Executive Director, Policy Research Institute. Illustration: TBS

Twin shocks call for stronger domestic policy response

2h | Thoughts
December-er shohor, taxi taken for airport and the Park Street bathed in lights. Photo: Jannatul Naym Pieal

Exploring Kolkata on foot, empowered by Google Maps

2h | Explorer
Island hopping in Bangladesh?

Island hopping in Bangladesh?

4h | Panorama

More Videos from TBS

Kajol’s road paintings bring change in Gafargaon

Kajol’s road paintings bring change in Gafargaon

16h | TBS Stories
Carew & Company witnessed a remarkable growth

Carew & Company witnessed a remarkable growth

17h | TBS Stories
PCB recalls cricketers from BPL ahead of PSL

PCB recalls cricketers from BPL ahead of PSL

19h | TBS SPORTS
Why Misha Sawdagar became villain instead of a Hero?

Why Misha Sawdagar became villain instead of a Hero?

18h | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Four top bankers arrested in DSA case filed by S Alam group 
Bangladesh

Four top bankers arrested in DSA case filed by S Alam group 

3
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]